Antithrombotic Treatment in Patients With Effectively Maintained Sinus Rhythm After Atrial Fibrillation Ablation

Summary

The purpose of the study is to investigate the best strategy for long-term stroke prevention in patients who have sinus rhythm after a successful catheter ablation for atrial fibrillation (AF) and who are at risk of thromboembolic events (CHA2DS2-VASc score ≥2). The investigators are going to compare antiplatelet therapy to oral anticoagulation (OAC) with different doses of edoxaban (30mg and 60mg).

Timeline

Start

2017-02-23

Primary completion

2019-12-15

Completion

2019-12-15

Outcome

Outcome not reported

Stopped (Enrollment): “Majority of enrolled patients have withdrawn.”

Drugs

Indications